Does Neoatherosclerosis Contribute to Very Late Stent Thrombosis of BMS and DES? - Michael Joner, MD

↳ This is a section part of Moment: CRT 2015 Technology & Innovation - DES Thrombosis Restenosis and DAPT Duration

Add this Moment to your Passport

Learn from this moment and keep it forever.
Add To Passport
$10.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Preview

Summary

Does Neoatherosclerosis Contribute to Very Late Stent Thrombosis of BMS and DES? presented by Michael Joner, MD at CRT 2015

Add this Moment to your Passport

Learn from this moment and keep it forever.
Add To Passport
$10.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Target Audience

  • Interventional Cardiologists
  • Interventional Fellows
  • Physicians with an interest in Cardiovascular Innovations 

Session Name: DES Thrombosis Restenosis and DAPT Duration 

Track: Technology & Innovation

Learning Objectives

  • Updates in the latest Cardiovascular Innovations

Other Components in this Moment

Overview
DES Thrombosis: Is It Still a Problem in 2015? - Donald E. Cutlip, MD
Dual Antiplatelet Therapy After DES: When Is It Safe to Stop? A Global Perspective - R. A. Byrne, MB BCh PhD
DES Restenosis Management in 2015 - Azeem Latib, MD
Does Neoatherosclerosis Contribute to Very Late Stent Thrombosis of BMS and DES? - Michael Joner, MD
Will Point of Care and Genomic Testing Have a Role in Day-to-Day Practice? - Paul A. Gurbel, MD
Lessons from DAPT In-Depth Analysis - Laura Mauri, MD
Loading Simple Education